Table 2 Demographic data of the current GCMR cohort
Characteristics of cases in GCMR | |||
|---|---|---|---|
Patient characteristics | Percentage of missing data | ||
Whole cohort, N = 62,456 | GCMR endorsed database, N = 23,781 | ||
Age (years), median (Q1, Q3) | 55 (40, 68) | 3% | 0.001% |
Female sex, % | 31.6 | 3% | 0.0004% |
Height (m), median (Q1, Q3) | 1.7 (1.6, 1.8) | 14% | 2% |
Weight (kg), median (Q1, Q3) | 79.5 (66.0, 93.8) | 14% | 2% |
BSA (m2), median (Q1, Q3) | 1.9 (1.6, 2.1) | 14% | 2% |
Cardiac Function, median (Q1, Q3) | |||
LVEDV (ml) | 145.0 (115.0, 182.0) | 15% | 10% |
LVESV (ml) | 57.7 (41.0, 83.0) | 15% | 10% |
LVEF, calculated or estimated (%) | 59.6 (51.2, 66.0) | 10% | 10% |
LV Mass (gram) | 118.0 (91.0, 154.0) | 34% | 19% |
RVEDV (ml) | 131.0 (96.0, 168.0) | 62% | 17% |
RVESV (ml) | 54.6 (35.0, 77.1) | 62% | 17% |
LVEDVI (ml/m2) | 79.6 (63.2, 110.0) | 17% | 11% |
LVESVI (ml/m2) | 33.2 (37.0, 23.5) | 17% | 11% |
Cardiac History, % | |||
History of MI | 13.6 | 15% | 6% |
History of PCI | 12.7 | 16% | 6% |
History of CABG | 5.5 | 16% | 6% |
History of HTN | 41.8 | 15% | 6% |
History of DM | 15.0 | 15% | 6% |
Rest wall motion abnormality, % | 26.4 | 19% | 9% |
Abnormal late gadolinium enhancement, % | 12.5 | 37% | 9% |